feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouIndiaIndia
You
bookmarksYour BookmarkshashtagYour Topics
Trending
Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2026 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / Cold Laser Therapy Offers New Hope for Prostate Cancer

Cold Laser Therapy Offers New Hope for Prostate Cancer

28 Jan

•

Summary

  • New cold laser therapy shows 84% tumor eradication in prostate cancer patients.
  • Treatment preserves quality of life with significantly fewer side effects.
  • Australian researchers lead study on this innovative focal therapy.
Cold Laser Therapy Offers New Hope for Prostate Cancer

A groundbreaking cold laser therapy is emerging as a highly effective treatment for prostate cancer, significantly reducing the risk of debilitating side effects. Australian scientists have reported that this novel approach eradicated tumors in 84% of patients participating in a recent trial.

This focal therapy utilizes high-dose laser light, converted to thermal energy, delivered through ultra-fine needles. The needles precisely target cancerous tumors within the prostate, destroying cancer cells while leaving surrounding healthy tissue unharmed. This method offers a promising alternative to conventional treatments like surgery and radiotherapy, which are associated with higher rates of incontinence and erectile dysfunction.

In a study involving 100 patients with stage two or three prostate cancer, researchers observed an 84% success rate in eradicating tumors after a three-month follow-up. While a small percentage of patients reported adverse effects like erectile dysfunction and a decline in urinary function, these rates were substantially lower than those seen with traditional methods.

This innovative treatment is currently being offered in a limited number of NHS hospitals in London and the South-East of England. Despite promising results, health watchdog the National Institute for Health and Care Excellence advises caution until further evidence on its long-term effectiveness is gathered. The development marks a significant advancement in prostate cancer care, prioritizing both cancer control and patient quality of life.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
The new cold laser therapy has shown an 84% success rate in eradicating tumors in patients with stage two or three prostate cancer.
The cold laser therapy results in significantly lower rates of side effects like incontinence and erectile dysfunction compared to traditional treatments.
This treatment is currently available in a handful of NHS hospitals, primarily in London and the South-East of England.

Read more news on

Healthside-arrowLondonside-arrow
trending

Ajit Pawar plane crash

trending

Hindustan Copper wins copper block

trending

Oliver Peake leads Australia U19

trending

HAL order book strong

trending

Union Bank Uttar Pradesh growth

trending

PNB expands digital banking presence

trending

Redmi Note 15 Pro+ debuts

trending

Shelton faces Sinner challenge

trending

Towing van helper arrested

You may also like

UK Leaders Discuss Widening Prostate Cancer Checks

14 hours ago • 4 reads

article image

Prostate Cancer Now Britain's Most Common Cancer

20 Jan • 47 reads

article image

New Blood Test Promises Smarter Prostate Cancer Screening

12 Jan • 71 reads

article image

Dietary Supplements Halt Prostate Cancer Progression

7 Jan

article image

Prostate Cancer Test Debate: Lives at Risk

5 Dec, 2025 • 235 reads

article image